Day 02 : RHEUMA IMMUNOCON Agenda

  • 12th April 2026
  • ITC Welcome Hotels, Gurgaon Road, New Delhi
RHEUMA IMMUNOCON 2026 – Day 2 Scientific Agenda
TIME TOPIC FACULTY
09:00 – 10:00 AM Registration & Breakfast —
10:00 – 10:10 AM Welcome Address
Opening Remarks – ARDF 		Cipla Medical
Dr. S J Gupta
Session 1: Axial SpA (10:10 – 11:10 AM)
Chairperson: Dr. (Lt General) Ved Chaturvedi | Moderator: Dr. P D Rath
10:10 – 10:30 AM Long-Term Perspectives on Secukinumab: Transforming axSpA Management International Speaker: Prof. Dr. Xenofon Baraliakos
10:30 – 10:40 AM Q & A —
10:40 – 11:15 AM Panel Discussion – Biologics in axSpA: Navigating Choices for Optimal Care Panelists:
Dr. Vishad Viswanath,
Dr. Mithun C B,
Dr. Shashank Akerkar,
Dr. Anuj Shukla,
Dr. Bhowmik Meghnathi
Session 2: Rheumatoid Arthritis (11:15 AM – 12:05 PM)
Chairperson: Prof. (Dr.) Rohini Handa | Moderator: Dr. Padmanabha Shenoy
11:15 – 11:30 AM HIT 1: MTX IR RA with cardiometabolic risk: JAK inhibitor use Dr. Ashit Syngle
11:30 – 11:45 AM HIT 2: RA-ILD and Biologics: Interpreting the Evidence Dr. Santosh Mondal
11:45 AM – 12:00 PM Tocilizumab’s CV Paradox in RA Dr. Arghya Chattopadhyay
Session 3: Pediatric Rheumatology (12:00 – 12:55 PM)
Chairperson & Moderator: Dr. Sujata Sawhney
12:00 – 12:20 PM Pediatric Rheumatology Update 2026: Practice-Changing Trials Shaping Tomorrow’s Care Dr. Suma Balan
12:20 – 12:50 PM Panel Discussion Dr. Priyankar Pal
Dr. Narendra K Bagri
Dr. Chandrika Bhat
Dr. Sathish Kumar T.
12:50 – 1:45 PM Lunch
Session 4: Cross Talks (1:45 – 2:30 PM)
Chairpersons: Dr. Prasanta Padhan | Dr. Sunil Sanghi
1:45 – 2:10 PM Psoriatic Disease 2026: Bridging Dermatology & Rheumatology for Unified Care Dr. Abir Saraswat
Dr. Kabir Sardana
Dr. Ajit Nalawade
Dr. Sumeet Aggarwal
2:10 – 2:25 PM Immune Crossroads: Allergy, Urticaria, and Autoimmunity Dr. Bimlesh Dhar Pandey
Dr. Vijay Warad
Dr. Rajiv Sekhri
Session 5: WIN (What Is New) (2:30 – 3:30 PM)
Chairperson: Dr. R N Misra | Moderator: Dr. Sundeep Upadhyaya
(Each session: 12 mins + 3 mins Q & A)
2:30 – 2:45 PM Cytokine Storm (Still’s/MAS): Rapid Recognition & Tiered Intervention Dr. Pravin Patil
2:45 – 3:00 PM Managing the Unpredictable: Advanced Approaches to HAE Dr. Ankur Jindal
3:00 – 3:15 PM What I’ll Do Differently on Monday Morning: A 10-Point TNFi Update Dr. Pradeep Kumar
3:15 – 3:30 PM Secukinumab in Psoriatic Arthritis: Sustained Long-Term Outcomes Dr. Ashish Mathew
Session 6: Lupus Breakthroughs (3:30 – 4:00 PM)
Chairperson: Dr. Vineeta Shobha | Moderator: Dr. Sapan Pandya
3:30 – 4:00 PM Panel Discussion: Lupus Therapy Evolution — From Current Standards to Future Breakthroughs Dr. Ranjan Gupta
Dr. Anupam Wakhlu
Dr. Pradip Kumar Sarma
Session 7: Debate (4:00 – 4:45 PM)
Chairperson: Dr. A K Khan | Moderator: Dr. Shyamashis Das
4:00 – 4:15 PM Debate: JAK Inhibitors in Focus — Is Broader Always Better? —
4:15 – 4:30 PM Pan-JAK Inhibitor Dr. Nilesh Nolkha (Pan JAK)
4:30 – 4:35 PM Specific JAK Inhibitor Dr. Sanjiv Kapoor (Specific JAK)
4:35 – 4:40 PM Rebuttals —
4:40 – 4:45 PM Closing Remarks & Thank You ARDF | Cipla Team

Message from Organiser

Dr. S J Gupta
Dr. S J Gupta
Prof. (Dr.) Rohini Handa
Prof. (Dr.) Rohini Handa

Arthritis & Rheumatic Diseases Foundation (ARDF)

Dear Sir/Madam,

The Arthritis & Rheumatic Diseases Foundation (ARDF) is pleased to invite you to participate in RHEUMA IMMUNOCON 2026, a Continuing Medical Education (CME) program focused on contemporary advances in Rheumatology. This academic initiative brings together national and international faculty for high-value clinical discourse across autoimmune and musculoskeletal diseases.

The Scientific Program of RHEUMA IMMUNOCON 2026 is structured around seven thematic clinical sessions featuring lectures, case-based discussions, debates, and multidisciplinary interactions.

Core Focus Areas Include:
  • Axial Spondyloarthritis
  • Rheumatoid Arthritis
  • Pediatric Rheumatology
  • Psoriatic Disease & Immunodermatology
  • WIN Series: Cytokine Storm, Angioedema & Targeted Therapy Updates
  • Lupus Breakthroughs & Emerging Biologics
  • JAK Inhibitor Perspectives – Clinical Debate
This CME Aims To:
  • Disseminate evidence-based clinical updates
  • Highlight breakthrough therapeutics and diagnostic strategies
  • Encourage cross-specialty collaboration
  • Foster dialogue between experts, trainees, and practicing clinicians

We look forward to your presence and active engagement at Rheuma Immunocon 2026.

Warm Regards,

Dr. S J Gupta
Chair ARDF

Yours sincerely,

Prof. (Dr.) Rohini Handa
Secretary, ARDF

Ready to Elevate Your Practice?

Join leading rheumatology professionals for two impactful days of learning, collaboration, and
innovation. Early bird registration is ending soon.

Register For Day 01
Register For Day 02

Academic Partner

Disclaimer: Unauthorized/unintended participants shall be fully responsible for all consequences and liabilities arising from taking part or listening in. Medical and related views expressed by the speakers are their independent opinions and Cipla does not endorse the same & disclaims any liability or information. Any introduction of speakers is merely symbolic and is not aimed at inviting any special attention to their respective professional positions. Copying, reproduction, circulation of the information in any form or by any means, print or electronically without Cipla's prior consent is strictly prohibited. For the use of a Registered Medical Practitioner or a Hospital a Laboratory only.